BiomEdit

Raised $18.4M in a Series B round, announced 15 July 2025.

Total raised
$18.4M

Latest round Series BCountry United StatesSector Health

Round

$18.4MSeries B, 15 July 2025

Funds BiomEdit through USDA conditional licensure and commercial launch of BE-101 in 2026.

Amount
$18.4M
Stage
Series B
Announced
15 July 2025
Lead
Anterra Capital
Other investors
Nutreco, AgriZeroNZ, Elevate Ventures, Betagro
Use of funds
Funds BiomEdit through USDA conditional licensure and commercial launch of BE-101 in 2026.
Checked
Amount and date matched across 2 press sources
Sources
BiomEdit raises $20M (date approx) agnavigator.com
BiomEdit raises $20M (date approx) pulse2.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Develops probiotic-delivered antibodies for poultry disease, spun out of Elanco and Ginkgo

Based in
United States
Sector
Health
Website
biomedit.com ↗

Links

Website
biomedit.com ↗

Questions

How much has BiomEdit raised?

BiomEdit raised $18.4M in a Series B round, announced on 15 July 2025.

Who invested in BiomEdit?

Anterra Capital led. Investors include Anterra Capital, Nutreco, AgriZeroNZ, Elevate Ventures and Betagro.